Carvedilol Changes Cirrhosis Care
1:26:19–1:27:29 · 70s
Suchita Sata details the CARVE-AS trial showing carvedilol reduces ascites recurrence and AKI in cirrhosis with portal hypertension—even without varices—shifting first-line therapy.
1:26:19–1:27:29 · 70s
Suchita Sata details the CARVE-AS trial showing carvedilol reduces ascites recurrence and AKI in cirrhosis with portal hypertension—even without varices—shifting first-line therapy.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.